During the last session, Emergent Biosolutions Inc (NYSE:EBS)’s traded shares were 0.6 million, with the beta value of the company hitting 2.06. The 52-week high for the EBS share is $15.10, that puts it down -226.84 from that peak though still a striking 60.61% gain since the share price plummeted to a 52-week low of $1.82. The company’s market capitalization is $251.04M, and the average intraday trading volume over the past 10 days was 0.99 million shares, and the average trade volume was 1.23 million shares over the past three months.
Emergent Biosolutions Inc (EBS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. EBS has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Emergent Biosolutions Inc (NYSE:EBS) trade information
The stock’s 5-day price performance is 8.45%, and it has moved by -20.89% in 30 days. Based on these gigs, the overall price performance for the year is 136.92%. The short interest in Emergent Biosolutions Inc (NYSE:EBS) is 8.97 million shares and it means that shorts have 6.12 day(s) to cover.
The consensus price target of analysts on Wall Street is $51.5, which implies an increase of 91.03% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $38 and $65 respectively. As a result, EBS is trading at a discount of -1306.93% off the target high and -722.51% off the low.
EBS Dividends
Emergent Biosolutions Inc is due to release its next quarterly earnings on 2025-Mar-02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Emergent Biosolutions Inc (NYSE:EBS)’s Major holders
Emergent Biosolutions Inc insiders own 2.28% of total outstanding shares while institutional holders control 64.14%, with the float percentage being 65.63%. BLACKROCK INC. is the largest shareholder of the company, while 192.0 institutions own stock in it. As of 2024-06-30, the company held over 3.84 million shares (or 7.2992% of all shares), a total value of $26.18 million in shares.
The next largest institutional holding, with 3.67 million shares, is of VANGUARD GROUP INC’s that is approximately 7.0234% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $25.0 million.
Also, the Mutual Funds coming in first place with the largest holdings of Emergent Biosolutions Inc (EBS) shares are American Century ETF Trust-Avantis U.S. Small Cap Value ETF and SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF . Data provided on Mar 31, 2025 indicates that American Century ETF Trust-Avantis U.S. Small Cap Value ETF owns about 1.94 shares. This amounts to just over 3.56 percent of the company’s overall shares, with a $8.95 million market value. The same data shows that the other fund manager holds slightly less at 1.61, or about 2.96% of the stock, which is worth about $7.43 million.
